Patent Assignment
Reel/Frame 033692/0660
Change of Name
Recorded: 2014-09-05
Pages: 4
Assignor
PRO-NEURON, INC.
Executed: 2002-05-15
Assignee
WELLSTAT THERAPEUTICS CORPORATION
930 CLOPPER ROAD, GAITHERSBURG, MARYLAND, 20878
Covered Properties
(5)
Method of Delivering Exogenous Uridine or Cytidine Using Acylated Uridine or Cytidine
Patent:
5,470,838 →
Application:
07/997,657 →
Acylated Uridine and Cytidine for Elevating Tissue Uridine and Cytidine
Patent:
5,583,117 →
Application:
08/140,475 →
Acylated Uridine and Cytidine and Uses Thereof
Patent:
6,316,426 →
Application:
08/466,144 →
Acylated Uridine and Cytidine and Uses Thereof
Patent:
6,258,795 →
Application:
08/466,145 →
Acylated Uridine and Cytidine and Uses Thereof
Patent:
6,274,563 →
Application:
08/479,349 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 18, 2012
From: BAMAT, MICHAEL K.; VON BORSTEL, REID W.
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 029493/0148 →
Change of Name
Dec 18, 2012
From: PRO-NEURON
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 029495/0448 →
Merger
Sep 5, 2014
From: WELLSTAT THERAPEUTICS CORPORATION
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 033674/0573 →
Assignment of Assignor's Interest
Sep 5, 2014
From: VON BORSTEL, REID W.; BAMAT, MICHAEL K.
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 033674/0729 →
Release of Certain Intellectual Property Collateral Owned by Wellstat Therapeutics Corporation Recorded at Reel 031227/Frame 0227
Jun 30, 2023
From: PDL BIOPHARMA, INC.
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 064180/0456 →
Assignment of Assignor's Interest
Nov 14, 2024
From: WELLSTAT THERAPEUTICS CORPORATION
To: BTG INTERNATIONAL INC.
Reel/Frame 069259/0699 →